# The Medicines (Applications for Grant of Product Licences—Products for Human Use) Regulations 1993, Paragraph 19


A statement indicating—
(a) which of the following should apply to the product, that is to say that the product should be available:
(i) on prescription only (that is to say, that it should be subject to restrictions imposed by section 58(2)(a) or 60(1)(b) of the Act);
(ii) only from a pharmacy (that is to say, that it should be subject to a restriction under section 52 or section 53 of the Act to the effect that it may be sold only at a registered pharmacy, but not subject to the restrictions imposed by section 58(2)(a) or 60(1)(b) of the Act); or
(iii) on general sale (that is to say, that it should not be subject to any of the restrictions referred to in paragraphs (i) and (ii) above); and
(b) what, if any, provisions of the licence are proposed concerning the method of sale or supply of the product (including, in particular, any proposed restrictions affecting the circumstances of the use or promotion of the product).

---
Source: https://www.legislation.gov.uk/uksi/1993/2538/schedule/1/paragraph/19 (the official version)
Page: https://openlegislation.uk/medicines-applications-for-grant-of-product-licencesproducts-for-human-use-regulations-1993/schedule-1/paragraph-19
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

